Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians.

Kim NH, Mason CC, Nelson RG, Afton SE, Essader AS, Medlin JE, Levine KE, Hoppin JA, Lin C, Knowler WC, Sandler DP.

Am J Epidemiol. 2013 May 1;177(9):962-9. doi: 10.1093/aje/kws329. Epub 2013 Mar 15.

2.

Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.

Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, Crainiceanu CM, Silbergeld EK, Guallar E, Navas-Acien A.

Am J Epidemiol. 2012 Nov 15;176(10):865-74. doi: 10.1093/aje/kws153. Epub 2012 Oct 24.

3.

Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review.

Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, Silbergeld EK, Styblo M, Tseng CH, Thayer KA, Loomis D.

Environ Health Perspect. 2012 Dec;120(12):1658-70. doi: 10.1289/ehp.1104579. Epub 2012 Aug 10. Review.

4.

Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006.

Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E.

Epidemiology. 2009 Nov;20(6):816-20; discussion e1-2. doi: 10.1097/EDE.0b013e3181afef88. No abstract available.

5.

Arsenic exposure and prevalence of type 2 diabetes in US adults.

Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E.

JAMA. 2008 Aug 20;300(7):814-22. doi: 10.1001/jama.300.7.814.

PMID:
18714061
6.

Arsenic metabolites in human urine after ingestion of an arsenosugar.

Francesconi KA, Tanggaar R, McKenzie CJ, Goessler W.

Clin Chem. 2002 Jan;48(1):92-101.

Supplemental Content

Support Center